MORGAN STANLEY PLC/CALL/MERCK & CO./160/0.1/20.06.25 Share Price

Warrant

DE000MB5BXW5

Market Closed - Börse Stuttgart 12:13:55 21/05/2024 am IST
0.32 EUR +6.67% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./160/0.1/20.06.25
Current month-5.88%
3 months-3.03%
Date Price Change
20/24/20 0.32 +6.67%
17/24/17 0.3 -3.23%
16/24/16 0.31 0.00%
15/24/15 0.31 +14.81%
14/24/14 0.27 -3.57%

Delayed Quote Börse Stuttgart

Last update May 21, 2024 at 12:13 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB5BXW
ISINDE000MB5BXW5
Date issued 05/04/2023
Strike 160 $
Maturity 20/06/2025 (396 Days)
Parity 10 : 1
Emission price 0.32
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.48
Lowest since issue 0.069
Spread 0.01
Spread %3.13%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131 USD
Average target price
141.6 USD
Spread / Average Target
+8.13%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW